In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
As of close of business last night, Liminatus Pharma Inc’s stock clocked out at $1.68, up 17.48% from its previous closing price of $1.43. In other words, the price has increased by $17.48 from its previous closing price. On the day, 5.26 million shares were traded. LIMN stock price reached its highest trading level at $1.74 during the session, while it also had its lowest trading level at $1.41.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LIMN now has a Market Capitalization of 45468580.
Stock Price History:
The Beta on a monthly basis for LIMN is 0.35, which has changed by -0.7910448 over the last 52 weeks, in comparison to a change of 0.16333759 over the same period for the S&P500. Over the past 52 weeks, LIMN has reached a high of $33.66, while it has fallen to a 52-week low of $1.12. The 50-Day Moving Average of the stock is -58.35%, while the 200-Day Moving Average is calculated to be -81.31%.
Shares Statistics:
It appears that LIMN traded 1.34M shares on average per day over the past three months and 1555950 shares per day over the past ten days. A total of 26.01M shares are outstanding, with a floating share count of 5.56M. Insiders hold about 79.47% of the company’s shares, while institutions hold 0.76% stake in the company. Shares short for LIMN as of 1756425600 were 311749 with a Short Ratio of 0.23, compared to 1753920000 on 230060.
